Navigation Links
Milestone Scientific to Exhibit at the Chicago Dental Society's 143rd Midwinter Meeting
Date:2/15/2008

LIVINGSTON, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it will be exhibiting at the upcoming Chicago Dental Society's 143rd Midwinter Meeting.

WHEN: Friday, February 22, 2008 - Sunday, February 24, 2008

WHERE: Booth #2206

McCormick Place Lakeside Center

2301 South Lake Shore Drive

Chicago, Illinois

WHO: Key Milestone officials, along with Henry Schein representatives,

will be available to discuss and demonstrate the STA(TM) System.

Learn first hand:

-- how Milestone is redefining the standard of care for the

delivery of local anesthesia in dentistry; and

-- how the STA System is promoting enhanced patient care and

improved practice efficiency for those dentists who have

adopted this novel technology since its unveiling at the 142nd

Midwinter Meeting last year.

Members of the press must register at the Press Booth for this event. For details on obtaining Press Credentials, please visit: http://www.cds.org/media/. To book a one-on-one meeting or demonstration, please contact John Morrison or Tiffany Korkis at 407-585-1080 or via email at mlss@efcg.net.

The Midwinter Meeting is among the top three dental meetings in the U.S. and one of the top 10 conventions in Chicago. Each year, more than 600 exhibiting companies participate in the meeting, creating one of the largest exhibits of dental products and manufacturers in North America. The theme for the 2008 Midwinter Meeting is "Charting Dental Success". The 2007 Midwinter Meeting drew more than 34,000 attendees and $48 million to the city of Chicago, including 7,793 dentists.

About the Chicago Dental Society

The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit their Web site at http://www.cds.org/.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

FOR MORE INFORMATION, PLEASE CONTACT:

Elite Financial Communications Group, LLC

Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer

407-585-1080 or via email at mlss@efcg.net


'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
2. Vendormate Storms into 2008 with Major Milestones for Hospital Vendor Compliance
3. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Transition Therapeutics Announces Milestone Payment from Elan
6. Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors
7. IBM reports milestone in silicon nanophotonics
8. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
9. Bavarian Nordic Receives $25 Million Milestone Payment From HHS for Fulfilling Contract Milestones
10. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , ... February 05, 2016 , ... ... the addition of micro-needling services in their Napa Valley office. The technique utilizes ... Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a ...
(Date:2/5/2016)... ... , ... US Sports Camps , official operators of Nike Yoga Camps, ... yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England city ... Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering with ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Boar’s Head ... just in time for this weekend’s Big Game. Take the stress out of your ... will keep your guests happy at every stage of the game. , “The key ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Ben ... that it is now welcoming orthodontist, Dr. Amanda Cheng, to the practice. With ... of oral health care, including general dentistry, cosmetic treatments, periodontics, implant dentistry ...
(Date:2/5/2016)... ... February 05, 2016 , ... On ... Rare Diseases, a continuing medical education (CME) event presented by the Association for ... kind—and a first for ACCORD, whose mission is to provide education, tools, and ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... -- Site Profile: --> ... Speech Recognition People, announced their latest primary healthcare case study where ... turnaround times and to save the practice money. Site ... Challenge: --> ,- Wirral CCG ,- VoicePower ... doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
(Date:2/4/2016)... 2016  Edwards Lifesciences Corporation (NYSE: EW ), ... disease and critical care monitoring, announced today that it ... with Morgan Stanley & Co. LLC to repurchase $325 ... of the Company,s previously authorized program to repurchase up ... --> --> Under ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
Breaking Medicine Technology: